Literature DB >> 2044124

Percutaneous biopsies of the breast: state of the art.

B D Fornage1.   

Abstract

Percutaneous biopsy of nonpalpable breast lesions can be performed using mammographic or ultrasound guidance. Stereotaxy is the only technique applicable to microcalcifications and very small masses. With few exceptions, discrete masses greater than 0.7-0.8 cm can be visualized on high-frequency sonograms. Because of the continuous real-time monitoring of the needle placement and of the sampling procedure, sonography has proved to be highly accurate and safe in experienced hands. In addition to depending on the accuracy of the radiologist in hitting the target and the accuracy of the cytopathologic diagnosis, the success of fine-needle aspiration biopsy depends on successful tissue extraction. The lack of significance of insufficient specimens and the importance of properly recording such results in the calculation of accuracy values for fine-needle aspiration biopsy are emphasized. On the other hand, confidence in a negative cytologic result (i.e., adequate specimen without malignant cells) of a perfectly guided procedure is a prerequisite for the nonsurgical management of nonpalpable breast masses and thus for reducing the number of surgical biopsies.

Mesh:

Year:  1991        PMID: 2044124     DOI: 10.1007/bf02635528

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  46 in total

1.  Contextual analysis complements single-cell analysis in the diagnosis of breast cancer in fine needle aspirates.

Authors:  R Detweiler; D J Zahniser; G L Garcia; M Hutchinson
Journal:  Anal Quant Cytol Histol       Date:  1988-02       Impact factor: 0.302

2.  Fine-needle aspiration of clinically occult breast lesions.

Authors:  D B Kopans
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

3.  Stereotaxic needle biopsy of non-palpable breast lesions. Cytologic and histopathologic findings.

Authors:  G Svane; C Silfverswärd
Journal:  Acta Radiol Diagn (Stockh)       Date:  1983

4.  Stereotaxic instrument for needle biopsy of the mamma.

Authors:  J Bolmgren; B Jacobson; B Nordenström
Journal:  AJR Am J Roentgenol       Date:  1977-07       Impact factor: 3.959

5.  Effects of needle aspiration on the mammographic appearance of the breast: a guide to the proper timing of the mammography examination.

Authors:  D L Klein; E A Sickles
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

6.  The value of aspiration cytology in the diagnosis of breast cancer: experience at the Fondation Curie.

Authors:  A Zajdela; N A Ghossein; J P Pilleron; A Ennuyer
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

7.  Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer.

Authors:  H J Wanebo; P S Feldman; M C Wilhelm; J L Covell; R L Binns
Journal:  Ann Surg       Date:  1984-05       Impact factor: 12.969

8.  Aspiration cytology is superior to Tru-Cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses.

Authors:  M M Shabot; I M Goldberg; P Schick; R Nieberg; Y H Pilch
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

9.  Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study.

Authors:  J Mouriquand; D Pasquier
Journal:  Acta Cytol       Date:  1980 Mar-Apr       Impact factor: 2.319

10.  Fine needle aspiration cytology, with immediate reporting, in the outpatient diagnosis of breast disease.

Authors:  T C Dehn; J Clarke; J M Dixon; V Crucioli; M J Greenall; E C Lee
Journal:  Ann R Coll Surg Engl       Date:  1987-11       Impact factor: 1.891

View more
  1 in total

1.  Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions.

Authors:  P J Drew; L W Turnbull; S Chatterjee; J Read; P J Carleton; J N Fox; J R Monson; M J Kerin
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.